Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Saturday, April 19, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
admin
-
April 11, 2025
Latest Pharma-News
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
admin
-
April 9, 2025
Latest Pharma-News
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
admin
-
April 9, 2025
Latest Pharma-News
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
admin
-
April 9, 2025
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
Bristol-Myers Squibb Announces Submission of Biologics License Application to the U.S. Food and Drug Administration (FDA) for CAR T-Cell Therapy Lisocabtagene Maraleucel (liso-cel)
admin
-
December 19, 2019
0
Latest Pharma-News
FDA Grants Accelerated Approval to Astellas’ and Seattle Genetics’ PADCEV™ (enfortumab vedotin-ejfv) for the treatment of locally Advanced or Metastatic Urothelial Cancer
admin
-
December 19, 2019
0
Latest Pharma-News
Novartis provides update on (fevipiprant) LUSTER Phase III studies in patients with uncontrolled GINA 4/5 asthma
admin
-
December 19, 2019
0
Latest Pharma-News
Roche concludes getting hold of Spark Therapeutics, Inc. to reinforce presence in gene therapy
admin
-
December 18, 2019
0
Latest Pharma-News
Enzalutamide Approved by FDA for metastatic castration-sensitive prostate cancer (mCSPC) Treatment
admin
-
December 18, 2019
0
Latest Pharma-News
Lynparza recommended by FDA advisory committee for 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer, not Progressed on Platinum-Based Chemotherapy
admin
-
December 18, 2019
0
Latest Pharma-News
Takeda collaborates with MiTest Health to Launch Innovative Disease Risk Prediction Tool to Redefine Crohn’s Disease Management
admin
-
December 18, 2019
0
Latest Pharma-News
Horizon Therapeutics first FDA-approved medicine Teprotumumab for the Treatment of Thyroid Eye Disease (TED)
admin
-
December 17, 2019
0
Latest Pharma-News
U.S. FDA Approved Avadel’s Nouress™ (AV001), a Cysteine Hydrochloride Injection for Treating Neonate Patients Requiring Total Parental Nutrition (TPN)
admin
-
December 17, 2019
0
Latest Pharma-News
FDA approved Salarius’s Seclidemstat by Fast Track Designation for Lead Drug Candidate, in Relapsed or Refractory Ewing Sarcoma
admin
-
December 17, 2019
0
Latest Pharma-News
AstraZeneca completed an Agreement with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia
admin
-
December 17, 2019
0
Latest Pharma-News
Soligenix initiates phase 1C, double-blind, placebo-controlled, phase 1C trial of RiVax, a lyophilized ricin toxin A-chain subunit vaccine with alum-adjuvant
admin
-
December 17, 2019
0
1
...
136
137
138
...
145
Page 137 of 145
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025